NEW YORK (GenomeWeb News) – Fitch Ratings placed the ratings of Thermo Fisher Scientific and Life Technologies on Rating Watch Negative following Thermo Fisher's announcement on Monday that it plans to buy Life Tech for $13.6 million.

Thermo Fisher's ratings that were placed on Rating Watch Negative include the company's long-term issuer default rating, which is rated BBB+; short-term IDR, rated F2; senior notes, rated BBB+; and commercial paper, rated F2.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.